Targeting the somatosensory system with AAV9 and AAV2retro viral vectors

被引:13
|
作者
Skorput, Alexander G. J. [1 ,4 ]
Gore, Reshma [1 ]
Schorn, Rachel [1 ]
Riedl, Maureen S. [1 ]
de Velasco, Ezequiel Marron Fernandez [2 ]
Hadlich, Bailey [1 ]
Kitto, Kelley F. [1 ]
Fairbanks, Carolyn A. [1 ,2 ,3 ]
Vulchanova, Lucy [1 ]
机构
[1] Univ Minnesota, Sch Med, Dept Neurosci, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Coll Pharm, Dept Pharmaceut, Minneapolis, MN 55455 USA
[4] Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Lebanon, NH USA
来源
PLOS ONE | 2022年 / 17卷 / 03期
基金
美国国家卫生研究院;
关键词
DORSAL-ROOT; SPINOPARABRACHIAL NEURONS; NEURAL PATHWAYS; GENE DELIVERY; PAIN; MOUSE; MICE; SEROTYPES; DEFINES; INPUT;
D O I
10.1371/journal.pone.0264938
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Adeno-associated viral (AAV) vectors allow for site-specific and time-dependent genetic manipulation of neurons. However, for successful implementation of AAV vectors, major consideration must be given to the selection of viral serotype and route of delivery for efficient gene transfer into the cell type being investigated. Here we compare the transduction pattern of neurons in the somatosensory system following injection of AAV9 or AAV2retro in the parabrachial complex of the midbrain, the spinal cord dorsal horn, the intrathecal space, and the colon. Transduction was evaluated based on Cre-dependent expression of tdTomato in transgenic reporter mice, following delivery of AAV9 or AAV2retro carrying identical constructs that drive the expression of Cre/GFP. The pattern of distribution of tdTomato expression indicated notable differences in the access of the two AAV serotypes to primary afferent neurons via peripheral delivery in the colon and to spinal projections neurons via intracranial delivery within the parabrachial complex. Additionally, our results highlight the superior sensitivity of detection of neuronal transduction based on reporter expression relative to expression of viral products.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Preventing PrPC Synthesis in Mice with Adeno-Associated Viral Vectors AAV2, AAV6 and AAV9
    DeArmond, Stephen
    Ahn, Misol
    Bajsarowicz, Krystyna
    Oehler, Abby
    Bankiewicz, Krystof
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2012, 71 (06): : 555 - 555
  • [2] Improved AAV1 and AAV9 Vectors for Gene Delivery
    Balakrishnan, Balaji
    Krishnagopal, Akshaya
    Sen, Dwaipayan
    Srivastava, Alok
    Jayandharan, Giridhara R.
    [J]. MOLECULAR THERAPY, 2013, 21 : S130 - S131
  • [3] Characterization of HSV Derived AAV9 Vectors
    Pechan, Peter
    Golebiowski, Diane
    Seregin, Alexey
    Zapata, Nicole
    Levi, Elise
    Kitsos, Christine
    Lu, Robert
    Amorrortu, Alvaro
    Morris, Carl
    [J]. MOLECULAR THERAPY, 2019, 27 (04) : 347 - 347
  • [4] Optimization of elution conditions for immunoaffinity chromatography of AAV5 and AAV9 vectors
    Iurlova, E. V.
    Rebelin, M. S.
    Stukanev, V. K.
    Perepelkina, M. P.
    Gershovich, P. M.
    Madera, D. A.
    Karabelskii, A. V.
    Ivanov, R. A.
    Prokofyev, A. V.
    [J]. HUMAN GENE THERAPY, 2019, 30 (11) : A24 - A25
  • [5] Targeting glioblastoma with nanobody-displaying AAV9
    Jargalsaikhan, S.
    Richter, N.
    Schaefer, W.
    Maire, C.
    Mohme, M.
    Lamszus, K.
    Piaggio, F.
    Malatesta, P.
    Thirion, C.
    Koch-Nolte, F.
    Mann, A. M.
    [J]. HUMAN GENE THERAPY, 2022, 33 (23-24) : A41 - A41
  • [6] Differential gene transfer to the choroid plexus after intrathecal delivery or in vitro exposure to AAV5, AAV8, and AAV9 viral vectors
    Churchill, C.
    Schuster, D.
    Schnell, S.
    Kitto, K.
    Peterson, C.
    Vulchanova, L.
    Fairbanks, C.
    [J]. JOURNAL OF PAIN, 2014, 15 (04): : S44 - S44
  • [7] Targeting AAV vectors
    Baker, AH
    [J]. MOLECULAR THERAPY, 2003, 7 (04) : 433 - 434
  • [8] Targeting transgene to the heart and liver with AAV9 by different promoters
    Chen, Bang-Dang
    He, Chun-Hui
    Chen, Xiao-Cui
    Pan, Shuo
    Liu, Fen
    Ma, Xiang
    Li, Xiao-Mei
    Gai, Min-Tao
    Tao, Jing
    Ma, Yi-Tong
    Yang, Yi-Ning
    Gao, Xiao-Ming
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2015, 42 (10): : 1108 - 1117
  • [9] A New Downstream Process for Large Scale Manufacturing of AAV9 Vectors
    Hebben, Matthias
    [J]. HUMAN GENE THERAPY, 2014, 25 (11) : A18 - A18
  • [10] Comparison of AAV8 and AAV9 microdystrophin as therapeutic vectors for the treatment of Duchenne's muscular dystrophy
    Foster, Helen
    Foster, Keith
    Athanasopoulos, Takis
    Trollet, Capucine
    Dickson, George
    [J]. HUMAN GENE THERAPY, 2008, 19 (10) : 1175 - 1175